Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population

Cancer Genetics

Volumn 205, Issue 9, 2012, Pages 432-435

  Forma, Ewa ^a   Krzeslak, Anna ^a   Wilkosz, Jacek ^b   Jozwiak, Pawel ^a   Szymczyk, Agnieszka ^a   Rozanski, Waldemar ^b   Brys, Magdalena ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Case control study; MT2A; Prostate cancer; SNP

Indexed keywords

METALLOTHIONEIN II;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METALLOTHIONEIN 2A GENE; MUTATOR GENE; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METALLOTHIONEIN; MIDDLE AGED; NEOPLASM STAGING; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84869821041     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.05.005     Document Type: Article

References (18)

1. Vasak M. Advances in metallothionein structure and functions. J Trace Elem Med Biol 2005, 19:13-17.
2. Theocharis S.E., Margeli A.P., Koutselinis A. Metallothionein: a multifunctional protein from toxicity to cancer. Int J Biol Markers 2003, 18:162-169.
3. Pedersen M.Ø., Larsen A., Stoltenberg M., et al. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 2009, 44:29-64.
4. Cherian M.G., Jayasurya A., Bay B.H. Metallothionein in human tumors and potential roles in carcinogenesis. Mutation Res 2003, 533:201-209.
5. Namdarghanbari M., Wobig W., Krezoski S., et al. Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J Biol Inorg Chem 2011, 16:1087-1101.
6. Dziegiel P. Expression of metallothionein in human cells. Pol J Pathol 2004, 55:3-12.
7. Kita K., Miura M., Yoshida M., et al. Potential effect on cellular response to cadmium of a single-nucleotide A -> G polymorphism in the promoter of the human gene for metallothionein IIA. Hum Genet 2006, 120:553-560.
8. Giacconi R., Cipriano C., Muti E., et al. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 2005, 6:407-413.
9. Giacconi R., Muti E., Malavolta M., et al. The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people. Mol Med 2007, 13:388-395.
10. Kayaalti Z., Söylemezoglu T. The polymorphism of core promoter region on metallothionein 2A-metal binding protein in Turkish population. Mol Biol Rep 2010, 37:185-190.
11. McElroy J.A., Bryda E.C., McKay S.D., et al. Genetic variation at a metallothionein 2A promoter single-nucleotide polymorphism in white and black females in Midwestern United States. J Toxicol Environ Health A 2010, 73:1283-1287.
12. Kayaalti Z., Mergen G., Söylemezoĝlu T. Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population. Toxicol Appl Pharmacol 2011, 245:252-255.
13. Kayaalti Z., Aliyev V., Söylemezoĝlu T. The potential effect of metallothionein 2A -5A/G single nucleotide polymorphism on blood cadmium, lead, zinc and copper levels. Toxicol Appl Pharmacol 2011, 256:1-7.
14. Tekin D., Kayaalti Z., Söylemezoĝlu T. The effects of metallothionein 2A polymorphism on lead metabolism: are pregnant women with a heterozygote genotype for metallothionein 2A polymorphism and their newborns at risk of having higher blood lead levels?. Int Arch Occup Environ Health 2011, Oct 18. [Epub ahead of print]. doi:10.1007/s00420-011-0711-y.
15. Yang L., Li H., Yu T., et al. Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications. Am J Physiol Endocrinol Metab 2008, 294:E987-E992.
16. Hasumi M., Suzuki K., Matsui H., et al. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett 2003, 200:187-195.
17. Cousins R.J., Liuzzi J.P., Lichten L.A. Mammalian zinc transport, trafficking, and signals. J Biol Chem 2006, 281:24085-24089.
18. Gumulec J., Masarík M., Krízková S., et al. Molecular mechanisms of zinc in prostate cancer. Klin Onkol 2011, 24:249-255.